We are a private biopharmaceutical company based in Southern California, founded in 2012 to realize the medical potential of over fifty years of research into the therapeutic use of low dose carbon monoxide as a therapeutic agent.. Our technology was co-invented by Edward Gomperts, a hematologist at Children’s Hospital Los Angeles with extensive biopharmaceutical industry experience.
A substantial pre-clinical literature h...
We are a private biopharmaceutical company based in Southern California, founded in 2012 to realize the medical potential of over fifty years of research into the therapeutic use of low dose carbon monoxide as a therapeutic agent.. Our technology was co-invented by Edward Gomperts, a hematologist at Children’s Hospital Los Angeles with extensive biopharmaceutical industry experience.
A substantial pre-clinical literature has elucidated the mechanism and efficacy of carbon monoxide and its target cytoprotective pathway, heme oxygenase, to reduce the inflammation and cell death associated with sickle cell disease and Parkinson’s disease
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.